HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Successful treatment of intrapericardial administration of carboplatin following systemic chemotherapy in a case of advanced thymic cancer with cardiac tamponade].

Abstract
A 72-year-old woman developed cardiac tamponade due to direct invasion of thymic cancer. Carboplatin was administered into the pericardial cavity two times with a total dose of 600 mg. Pericardial effusion disappeared without any toxicities. Following four cycles of systemic chemotherapy by carboplatin, doxorubicin, vincristine, cyclophosphamide (ADOC), partial response was obtained. She is alive 10 month after being given a diagnosis of cardiac tamponade. Intrapericardial administration of carboplatin is a useful therapy for control of pericardial effusion and chemosensitive cases should de identified among patients with thymic cancer.
AuthorsMitsuyo Okada, Tomonobu Koizumi, Masanori Yasuo, Kenji Tsushima, Kazuhisa Urushihata, Shinji Yamaguchi, Masayuki Hanaoka, Keisaku Fujimoto, Keishi Kubo
JournalNihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society (Nihon Kokyuki Gakkai Zasshi) Vol. 44 Issue 12 Pg. 968-72 (Dec 2006) ISSN: 1343-3490 [Print] Japan
PMID17233396 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Carboplatin
  • Cisplatin
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Carboplatin (administration & dosage)
  • Carcinoma, Squamous Cell (drug therapy, secondary)
  • Cardiac Tamponade (drug therapy, etiology)
  • Cisplatin (administration & dosage)
  • Cyclophosphamide (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Drug Administration Schedule
  • Female
  • Humans
  • Liver Neoplasms (secondary)
  • Pleural Effusion, Malignant (drug therapy, etiology)
  • Remission Induction
  • Thymus Neoplasms (drug therapy, pathology)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: